The Addiction Grand Rounds (AGR) is a once monthly series facilitated by the Office of the Clinical Director (OCD). These meetings typically take place on the first Thursday of each month from 1pm-2pm. Following each presentation, the speaker will facilitate a discussion with trainees only, from 2pm-3pm . These meetings are offered in a hybrid format and take place at the NIDA IRP Biomedical Research Center (BRC). Speakers include a variety of clinicians and clinical scientists, working with alcohol and substance use disorders as well as those working in mental health and clinical neuroscience in general.
Sign language interpreting services are available upon request. Individuals who need interpreting services and/or other reasonable accommodations to participate in any NIDA IRP Hosted Event should contact Wendy Marshall. Requests should be made five (5) days in advance of the event.
For Telecommunications Relay Service (TRS) call 711.
https://ors.od.nih.gov/pes/emb/interpret/Pages/default.aspx
Upcoming Seminars
Thursday, May 1, 2025
1-2pm (2-3pm for trainees)
Michael Bauman, PhD
NIDA IRP Designer Drug Research Unit
Topic
New psychoactive substances (NPS) appearing in US non-medical drug markets
Location
BRC 03C219
Virtual: Contact Wendy Marshall for Link
Host
Lorenzo Leggio, M.D., Ph.D.
About William Stoehr
Michael H. Baumann, PhD, is a Staff Scientist and Unit Director at the National Institute on Drug Abuse (NIDA), Intramural Research Program (IRP), in Baltimore, MD. In 2014, he established the Designer Drug Research Unit (DDRU) to collect, analyze, and disseminate the most up-to-date information about the pharmacology and toxicology of newly emerging synthetic drugs of abuse, known as new psychoactive substances (NPS). Working with partner organizations such as the Center for Forensic Science Research and Education (CFSRE) and the European Union Drug Agency (EUDA) , Dr. Baumann is kept informed about global trends in NPS misuse. His research team has characterized the molecular mechanisms of action for many “bath salts” cathinones, “spice” cannabinoids, and “nitazene” opioids. Ongoing research is aimed at investigating the biological effects of emerging stimulants, psychedelics, and opioids to determine their adverse effects and potential therapeutic utility.
